CAS: 173529-46-9 - (E)-N-Acetyl-4-methoxy-N-[2-[2-(1-oxidopyridin-4-yl)vinyl]phenyl]benzenesulfonamide
Formula:C22H20N2O5S
InChI:InChI=1S/C22H20N2O5S/c1-17(25)24(30(27,28)21-11-9-20(29-2)10-12-21)22-6-4-3-5-19(22)8-7-18-13-15-23(26)16-14-18/h3-16H,1-2H3/b8-7+
InChI key:InChIKey=OCKHRKSTDPOHEN-BQYQJAHWSA-N
SMILES:O=C(N(C=1C=CC=CC1C=CC2=CC=N(=O)C=C2)S(=O)(=O)C3=CC=C(OC)C=C3)C
- Synonyms:
- (E)-4-[2-[2-[N-Acetyl-N-[(p-methoxyphenyl)sulfonyl]amino]phenyl]ethenyl]pyridine 1-oxide
- Acetamide, N-[(4-methoxyphenyl)sulfonyl]-N-[2-[(1E)-2-(1-oxido-4-pyridinyl)ethenyl]phenyl]-
- Acetamide, N-[(4-methoxyphenyl)sulfonyl]-N-[2-[2-(1-oxido-4-pyridinyl)ethenyl]phenyl]-, (E)-
- Hmn-214
- Ivx 214
- N-[(4-Methoxyphenyl)sulfonyl]-N-[2-[(1E)-2-(1-oxido-4-pyridinyl)ethenyl]phenyl]acetamide
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Acetamide, N-[(4-methoxyphenyl)sulfonyl]-N-[2-[(1E)-2-(1-oxido-4-pyridinyl)ethenyl]phenyl]- REF: IN-DA001Z05CAS: 173529-46-9 | 98% | 50.00 €~522.00 € | Mon 16 Dec 24 | |
HMN-214 REF: TM-T2438CAS: 173529-46-9 | 100% - 98.63% | 40.00 €~1,096.00 € | Mon 23 Dec 24 | |
HMN-214 REF: 3D-FH170580CAS: 173529-46-9 | Min. 95% | - - - | Discontinued product |
Acetamide, N-[(4-methoxyphenyl)sulfonyl]-N-[2-[(1E)-2-(1-oxido-4-pyridinyl)ethenyl]phenyl]-
CAS:173529-46-9
Formula:
C22H20N2O5S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
424.4696
Ref: IN-DA001Z05
1mg | 50.00 € | ||
5mg | 116.00 € | ||
10mg | 144.00 € | ||
25mg | 157.00 € | ||
50mg | 237.00 € | ||
100mg | 341.00 € | ||
250mg | 522.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
HMN-214
CAS:173529-46-9
HMN-214 (IVX-214) is a potent PLK1 inhibitor with an average IC50 of 0.12 μM.
Formula:
C22H20N2O5S
Purity:
100% - 98.63%
Color and Shape:
Solid
Molecular weight:
424.47
Ref: TM-T2438
1mg | 40.00 € | ||
2mg | 52.00 € | ||
5mg | 84.00 € | ||
10mg | 123.00 € | ||
25mg | 216.00 € | ||
50mg | 347.00 € | ||
100mg | 498.00 € | ||
500mg | 1,096.00 € | ||
1mL*10mM (DMSO) | 91.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
HMN-214
CAS:173529-46-9
HMN-214 is a novel oral prodrug that is being developed as a single agent therapy …
Formula:
C22H20N2O5S
Purity:
Min. 95%
Molecular weight:
424.47 g/mol
Ref: 3D-FH170580
1mg | Discontinued | Request information | |
2mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information |